About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Ranolazine
- Company
- Swathy Chandrashekhar, MBBS
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 4 recruiting
Efficacy results: Not yet reported
4 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 19, 2026
Find a Clinical Trial Near Me
See recruiting studies for Ranolazine and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT04606459
COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina
Not yet reported Johannes Gutenberg University Mainz 144 participants Est. completion 2029-10-20 1 siteOther conditions: Coronary Microvascular Disease, Refractory AnginaView official trial listing → -
Recruiting NCT NCT06527222
A Study of Ranolazine in ALS
Not yet reported Swathy Chandrashekhar, MBBS 72 participants Est. completion 2028-07 6 sites Stand-aloneOther conditions: Amyotrophic Lateral SclerosisView official trial listing → -
Recruiting NCT NCT06570473
Feasibility Trial for a Right Ventricular Failure Platform Trial
Not yet reported University of Alberta 30 participants Est. completion 2027-06 5 sites Stand-aloneHeart failure Other conditions: Pulmonary Hypertension, Right Ventricular DysfunctionView official trial listing → -
Recruiting NCT NCT07380919
Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study
Not yet reported, Not yet reported Federico II University 100 participants Est. completion 2026-06 3 sites Stand-aloneOther conditions: STEMI (ST Elevation MI)View official trial listing → -
Completed NCT NCT00091429
Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine
Not yet reported Gilead Sciences 500 participants Est. completion 2005-02Other conditions: AnginaView official trial listing → -
Completed NCT NCT00099788
Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes
Not yet reported Gilead Sciences 6560 participants Est. completion 2007-02 1 site Stand-aloneOther conditions: Myocardial IschemiaView official trial listing → -
Completed NCT NCT00570089
Microvascular Coronary Disease In Women: Impact Of Ranolazine
Not yet reported Cedars-Sinai Medical Center 20 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Myocardial IschemiaView official trial listing → -
Terminated NCT NCT00574756
Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
Not yet reported University of California, San Diego 14 participants Est. completion 2010-03 1 siteHeart failure Other conditions: Ranolazine, Tissue Doppler Ultrasound, EchocardiographyView official trial listing → -
Completed NCT NCT00644332
An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)
Not yet reported Gilead Sciences 172 participants Est. completion 2011-01 29 sitesOther conditions: Chronic AnginaView official trial listing → -
Withdrawn NCT NCT00657514
Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
Not yet reported Colorado Prevention Center Est. completion 2009-06 3 sitesOther conditions: Peripheral Arterial Disease, AnginaView official trial listing → -
Terminated NCT NCT00832572
Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy
Not yet reported Gilead Sciences 5 participants Est. completion 2009-06 1 site Stand-aloneCardiovascular disease Other conditions: Pain, Peripheral Nervous System Diseases, PolyneuropathyView official trial listing → -
Terminated NCT NCT00914316
Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities
Not yet reported Corewell Health East 29 participants Est. completion 2013-03 1 siteOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Completed NCT NCT00998218
Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction
Not yet reported Aspirus Heart and Vascular Institute-Research and Education 7 participants Est. completion 2010-12 1 site Stand-aloneSubstance use disorder Other conditions: Ventricular ArrythmiasView official trial listing → -
Completed NCT NCT01163721
Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy
Not yet reported Gilead Sciences 80 participants Est. completion 2010-11 9 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01163734
Ranolazine in Diastolic Heart Failure
Not yet reported Gilead Sciences 20 participants Est. completion 2011-02 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT01174173
Ranolazine and Pulmonary Hypertension
Not yet reported Northwestern University 11 participants Est. completion 2014-10 1 site Stand-aloneOther conditions: Angina, Pulmonary Arterial HypertensionView official trial listing → -
Completed NCT NCT01215253
Ranolazine Implantable Cardioverter-Defibrillator Trial
Not yet reported University of Rochester 1012 participants Est. completion 2017-02-28 90 sitesHeart failure Other conditions: Ischemic Cardiomyopathy, Nonischemic CardiomyopathyView official trial listing → -
Completed NCT NCT01221272
Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Not yet reported Gilead Sciences 81 participants Est. completion 2012-09 43 sites Stand-aloneOther conditions: Myocardial Perfusion Imaging, Myocardial IschemiaView official trial listing → -
Status unknown NCT NCT01304095
Ranolazine, Ethnicity and the Metabolic Syndrome
Not yet reported Atlanta Heart Specialists, LLC 160 participants Est. completion 2013-11 2 sitesCardiovascular diseaseMetabolic syndrome Other conditions: AnginaView official trial listing → -
Withdrawn NCT NCT01334203
A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)
Not yet reported Gilead Sciences Est. completion 2012-12 Stand-aloneCardiovascular diseaseType 2 diabetes Other conditions: Angina PectorisView official trial listing → -
Completed NCT NCT01342029
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Not yet reported Cedars-Sinai Medical Center 142 participants Est. completion 2016-12 2 sites Stand-aloneOther conditions: Microvascular Coronary Dysfunction (MCD)View official trial listing → -
Completed NCT NCT01345188
Ranolazine in Ischemic Cardiomyopathy
Not yet reported Midwest Cardiovascular Research Foundation 28 participants Est. completion 2014-04 1 siteOther conditions: Cardiomyopathy, Chest Pain, DyspneaView official trial listing → -
Terminated NCT NCT01349491
Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion
Not yet reported University of Oklahoma 10 participants Est. completion 2014-06 2 sites Stand-aloneOther conditions: Atrial FibrillationView official trial listing → -
Terminated NCT NCT01352416
Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery
Not yet reported Corewell Health East 15 participants Est. completion 2012-11 2 sitesOther conditions: Heart; Dysfunction Postoperative, Cardiac SurgeryView official trial listing → -
Completed NCT NCT01425359
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Not yet reported Gilead Sciences 949 participants Est. completion 2012-10 135 sites Stand-aloneCardiovascular diseaseType 2 diabetes Other conditions: Angina PectorisView official trial listing → -
Completed NCT NCT01435174
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
Not yet reported University of Michigan 17 participants Est. completion 2013-03 1 site Stand-aloneCardiovascular disease Other conditions: End-stage Renal DiseaseView official trial listing → -
Completed NCT NCT01442038
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Not yet reported Gilead Sciences 2651 participants Est. completion 2015-02 218 sites Stand-aloneCardiovascular disease Other conditions: Angina PectorisView official trial listing → -
Completed NCT NCT01472185
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Not yet reported Gilead Sciences 465 participants Est. completion 2013-10 159 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01480336
The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
Not yet reported Hartford Hospital 19 participants Est. completion 2013-01 1 siteOther conditions: ArrhythmiaView official trial listing → -
Status unknown NCT NCT01490255
Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2014-06 2 sitesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01491061
Ranolazine Loading to Prevent PCI-induced Myocardial Injury
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2017-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01494987
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Not yet reported Gilead Sciences 431 participants Est. completion 2013-08 140 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT01495520
Ranolazine for Improving Symptoms of Palpitations
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2016-12Other conditions: Ischemic Heart DiseaseView official trial listing → -
Completed NCT NCT01505179
The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
Not yet reported University of California, San Diego 10 participants Est. completion 2015-01 1 siteHeart failureView official trial listing → -
Completed NCT NCT01522651
Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation
Not yet reported Gilead Sciences 134 participants Est. completion 2014-03-10 50 sites Stand-aloneOther conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT01534962
Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion
Not yet reported Menarini Group 241 participants Est. completion 2014-03 4 sites Stand-aloneOther conditions: Persistent Atrial FibrillationView official trial listing → -
Completed NCT NCT01546558
Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
Not yet reported Gilead Sciences 25 participants Est. completion 2012-03 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01546597
Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
Not yet reported Gilead Sciences 24 participants Est. completion 2012-03 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01555164
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
Not yet reported Gilead Sciences 442 participants Est. completion 2013-10 146 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT01558830
Safety of Amiodarone and Ranolazine Together in Patients With Angina
Not yet reported Cardiovascular Consultants of Nevada 50 participants Est. completion 2013-07 3 sitesCardiovascular disease Other conditions: Chronic Stable Angina, Atrial Fibrillation, Ventricular TachycardiaView official trial listing → -
Terminated NCT NCT01562041
Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease
Not yet reported Novartis Pharmaceuticals 14 participants Est. completion 2014-01-02 2 sites Stand-aloneOther conditions: Atherosclerotic Coronary Vascular DiseaseView official trial listing → -
Terminated NCT NCT01590979
Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
Not yet reported Northwell Health 54 participants Est. completion 2015-06 1 siteOther conditions: Atrial Fibrillation New Onset, Hemorrhage, Prolonged QTc Interval, Ventricular Tachycardia, Medical Care; Complications, Late Effect of ComplicationsView official trial listing → -
Completed NCT NCT01648205
Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients
Not yet reported University of Rochester 25 participants Est. completion 2018-07-20 1 site Stand-aloneOther conditions: Long QT SyndromeView official trial listing → -
Terminated NCT NCT01675973
A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine
Not yet reported Gilead Sciences 4 participants Est. completion 2012-08 1 site Stand-aloneOther conditions: Severe Renal ImpairmentView official trial listing → -
Completed NCT NCT01703156
Low Risk Acute Coronary Syndrome
Not yet reported University of Oklahoma 70 participants Est. completion 2012-07 1 site Stand-aloneOther conditions: Low Risk Acute Coronary SyndromeView official trial listing → -
Terminated NCT NCT01705509
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Not yet reported Cardiovascular Institute of the South Clinical Research Corporation 14 participants Est. completion 2017-03-31 1 siteOther conditions: CardiomyopathyView official trial listing → -
Completed NCT NCT01721967
Ranolazine for the Treatment of Chest Pain in HCM Patients
Not yet reported Duke University 14 participants Est. completion 2016-05 1 site Stand-aloneOther conditions: Hypertrophic CardiomyopathyView official trial listing → -
Status unknown NCT NCT01728025
Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
Not yet reported Tel-Aviv Sourasky Medical Center 10 participants Est. completion 2017-11 1 site Stand-aloneOther conditions: Long QT Syndrome Type 3View official trial listing → -
Completed NCT NCT01754259
Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
Not yet reported Brigham and Women's Hospital 47 participants Est. completion 2015-12 1 site Stand-aloneCardiovascular disease Other conditions: Diabetes, Type I, Diabetes, Type II, AnginaView official trial listing → -
Completed NCT NCT01757808
A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
Not yet reported University of Chicago 12 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Terminated NCT NCT01767987
Ranolazine Cardioprotection in PCI
Not yet reported Harvey Hahn 6 participants Est. completion 2014-04 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT01797484
Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia
Not yet reported, Not yet reported Universitätsklinikum Hamburg-Eppendorf 20 participants Est. completion 2015-06 1 siteCardiovascular disease Other conditions: Acute Myocardial IschemiaView official trial listing → -
Status unknown NCT NCT01804543
Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
Westside Medical Associates of Los Angeles 30 participants Est. completion 2014-12 1 siteOther conditions: Angina, Heart DiseaseView official trial listing → -
Status unknown NCT NCT01810796
Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial
Not yet reported Hadassah Medical Organization 300 participants Est. completion 2017-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01815957
Impact of Ranolazine on Coronary Microcirculatory Resistance
Not yet reported University of New Mexico 7 participants Est. completion 2016-03 1 site Stand-aloneCardiovascular disease Other conditions: Coronary Microcirculation, Myocardial Disease, IschemiaView official trial listing → -
Completed NCT NCT01839110
Targeting the Right Ventricle in Pulmonary Hypertension
Not yet reported University of Pennsylvania 22 participants Est. completion 2018-01 3 sitesOther conditions: Pulmonary HypertensionView official trial listing → -
Completed NCT NCT01843127
A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
Not yet reported Gilead Sciences 24 participants Est. completion 2013-09 3 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01873950
Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects
Not yet reported Food and Drug Administration (FDA) 22 participants Est. completion 2014-12 Stand-aloneOther conditions: Drug-induced Surface ECG ChangesView official trial listing → -
Terminated NCT NCT01887353
The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure
Not yet reported Intermountain Health Care, Inc. 8 participants Est. completion 2014-02 1 siteHeart failure Other conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT01917136
11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
Not yet reported University of Pennsylvania 21 participants Est. completion 2018-10 1 siteOther conditions: Pulmonary HypertensionView official trial listing → -
Completed NCT NCT01948310
Effects of Ranolazine and Exercise on Daily Physical Activity Trial
Not yet reported Duke University 38 participants Est. completion 2016-10-10 1 siteOther conditions: Chronic Stable AnginaView official trial listing → -
Status unknown NCT NCT01979965
Effect of Ranolazine on Valvular Disease in Patients With Pacemakers
Not yet reported University Cardiology 50 participants Est. completion 2014-09 1 siteOther conditions: Ischemic Mitral RegurgitationView official trial listing → -
Completed NCT NCT01992016
A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
Not yet reported University of Colorado, Denver 11 participants Est. completion 2018-04-11 1 site Stand-aloneOther conditions: Adenocarcinoma of the Prostate, Bone Metastases, Soft Tissue Metastases, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Status unknown NCT NCT01996618
Study to Reduce Symptoms of Premature Beats With Ranolazine
Not yet reported Walter Reed National Military Medical Center 72 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Premature Ventricular BeatsView official trial listing → -
Completed NCT NCT02052011
Ranolazine and Microvascular Angina by PET in the Emergency Department
Not yet reported Yale University 31 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: Microvascular AnginaView official trial listing → -
Completed NCT NCT02133352
Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
Not yet reported Boston University 10 participants Est. completion 2014-05 1 site Stand-aloneOther conditions: Pulmonary Hypertension, Diastolic Left Ventricular DysfunctionView official trial listing → -
Completed NCT NCT02133911
A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy
Not yet reported University Medical Centre Ljubljana 10 participants Est. completion 2016-04-02 1 site Stand-aloneOther conditions: Dilated CardiomyopathyView official trial listing → -
Completed NCT NCT02147067
Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
Not yet reported Emory University 26 participants Est. completion 2018-06 1 site Stand-aloneOther conditions: Microvascular AnginaView official trial listing → -
Terminated NCT NCT02147834
Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents
Not yet reported North Florida Foundation for Research and Education 5 participants Est. completion 2016-09 1 siteOther conditions: AnginaView official trial listing → -
Terminated NCT NCT02156336
Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)
Not yet reported Horizons International Peripheral Group 4 participants Est. completion 2017-02-08 3 sitesOther conditions: Diabetic Peripheral Neuropathic PainView official trial listing → -
Terminated NCT NCT02239926
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
Not yet reported, Not yet reported Mayo Clinic 5 participants Est. completion 2015-09 1 siteOther conditions: Diarrhea Predominant Irritable Bowel SyndromeView official trial listing → -
Completed NCT NCT02251457
Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
Not yet reported Ohio State University 35 participants Est. completion 2017-12-18 1 site Stand-aloneOther conditions: Myotonia Congenita, Paramyotonia Congenita, Myotonic Dystrophy 1View official trial listing → -
Completed NCT NCT02252406
Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
Not yet reported University of Florida 33 participants Est. completion 2019-05-17 1 site Stand-aloneMetabolic syndrome Other conditions: Stable AnginaView official trial listing → -
Completed NCT NCT02265796
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
Not yet reported North Florida Foundation for Research and Education 50 participants Est. completion 2016-09 1 siteOther conditions: AnginaView official trial listing → -
Completed NCT NCT02360397
Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
Not yet reported Kent Hospital, Rhode Island 6 participants Est. completion 2018-02-23 1 site Stand-aloneOther conditions: Ventricular Premature Complexes, Myocardial IschemiaView official trial listing → -
Withdrawn NCT NCT02423265
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
Not yet reported East Carolina University Est. completion 2017-03 1 siteCardiovascular disease Other conditions: Myocardial Ischemia, Arteriosclerosis, Chronic Stable AnginaView official trial listing → -
Completed NCT NCT02425969
A Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values
Not yet reported Golden Jubilee National Hospital 108 participants Est. completion 2016-10-01 1 site Stand-aloneOther conditions: Grey-zone Fractional Flow Reserve, Intermediate Coronary Lesions, Stable Angina, Coronary PhysiologyView official trial listing → -
Withdrawn NCT NCT02611596
Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics
Not yet reported Walter Reed National Military Medical Center Est. completion 2019-11 Stand-aloneType 2 diabetes Other conditions: Silent Myocardial IschemiaView official trial listing → -
Withdrawn NCT NCT02687269
Ranolazine a Potential New Therapeutic Application
Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS Est. completion 2020-10 Stand-aloneOther conditions: Myocardial StunningView official trial listing → -
Status unknown NCT NCT02817932
A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects
Not yet reported A.Menarini Asia-Pacific Holdings Pte Ltd 120 participants Est. completion 2016-10 1 site Stand-aloneOther conditions: Healthy Male IndividualsView official trial listing → -
Completed NCT NCT02829034
Targeting Right Ventricle in Pulmonary Hypertension Gilead
Not yet reported University of Pennsylvania 22 participants Est. completion 2018-01 3 sitesOther conditions: Pulmonary HypertensionView official trial listing → -
Status unknown NCT NCT03044964
Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention (REPTAR)
Not yet reported Amit Malhotra, MD 40 participants Est. completion 2017-10 1 siteOther conditions: AnginaView official trial listing → -
Completed NCT NCT03070470
CiPA Phase 1 ECG Biomarker Validation Study
Not yet reported Food and Drug Administration (FDA) 60 participants Est. completion 2017-06-26 1 siteOther conditions: Drug-induced QT Prolongation, Pharmacokinetics, PharmacodynamicsView official trial listing → -
Withdrawn NCT NCT03162120
Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation
Not yet reported, Not yet reported Elpen Pharmaceutical Co. Inc. Est. completion 2018-12-01Other conditions: Atrial Fibrillation, RecurrenceView official trial listing → -
Withdrawn NCT NCT03257683
RANOLAZINE STUDY: Speckle Tracking Derived Myocardial Strain
Saint Thomas Health Est. completion 2018-02-16 1 siteCardiovascular disease Other conditions: Ischaemic Myocardial DysfunctionView official trial listing → -
Completed NCT NCT03401502
A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency
Not yet reported TSH Biopharm Corporation Limited 20 participants Est. completion 2019-03-31 1 site Stand-aloneOther conditions: AnginaView official trial listing → -
Completed NCT NCT03472950
Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
Not yet reported University of Kansas Medical Center 14 participants Est. completion 2022-12-09 1 site Stand-aloneOther conditions: ALSView official trial listing → -
Status unknown NCT NCT03486561
Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)
Not yet reported OBS Pakistan 2000 participants Est. completion 2018-10-31Other conditions: Chronic Stable AnginaView official trial listing → -
Completed NCT NCT03953989
Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy
Not yet reported IRCCS San Raffaele 26 participants Est. completion 2020-03-06 1 site Stand-aloneOther conditions: HCM - Hypertrophic Non-Obstructive CardiomyopathyView official trial listing → -
Terminated NCT NCT04456517
Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy
Not yet reported Vanderbilt University Medical Center 4 participants Est. completion 2024-04-11 1 site Stand-aloneOther conditions: Crohn's Disease, Inflammatory Bowel DiseaseView official trial listing → -
Completed NCT NCT07054255
Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese Subjects
Not yet reported Haisco Pharmaceutical Group Co., Ltd. 72 participants Est. completion 2020-12-21 1 site Stand-aloneOther conditions: HealthyView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Ranolazine, Ranexa
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
